T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Viemed Healthcare
VMD
$353M
| $81K | ﹤0.01% |
11,008
+286
| +3% | +$2.04K |
|
2852
eHealth
EHTH
$39.7M
| $80K | ﹤0.01% |
19,400
-2,323
| -11% | -$10K |
|
|
OPI
2853
DELISTED
Office Properties Income Trust
OPI
| $80K | ﹤0.01% |
36,241
+16,300
| +82% | +$37K |
|
|
SGMO
2854
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $80K | ﹤0.01% |
92,000
-144,100
| -61% | -$106K |
|
2855
Mama's Creations
MAMA
$826M
| $78K | ﹤0.01% |
10,549
| – | – |
|
|
MRNS
2856
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $78K | ﹤0.01% |
44,200
| – | – |
|
|
CIO
2857
DELISTED
City Office REIT
CIO
| $77K | ﹤0.01% |
13,169
-53,243
| -80% | -$301K |
|
2858
Definitive Healthcare
DH
$69.4M
| $77K | ﹤0.01% |
17,076
| – | – |
|
2859
Nkarta
NKTX
$171M
| $77K | ﹤0.01% |
16,928
| – | – |
|
2860
Aemetis
AMTX
$126M
| $76K | ﹤0.01% |
32,735
| – | – |
|
|
ONL
2861
Orion Office REIT
ONL
$161M
| $76K | ﹤0.01% |
18,788
+335
| +2% | +$1.31K |
|
2862
Heron Therapeutics
HRTX
$64.7M
| $75K | ﹤0.01% |
37,495
| – | – |
|
|
EWCZ
2863
DELISTED
European Wax Center
EWCZ
| $74K | ﹤0.01% |
10,870
+202
| +2% | +$1.57K |
|
2864
RUM Group Inc
RUM
$3.74B
| $74K | ﹤0.01% |
13,700
| – | – |
|
2865
SES AI
SES
$212M
| $74K | ﹤0.01% |
114,196
+39,918
| +54% | +$41.6K |
|
2866
Radiant Logistics
RLGT
$400M
| $73K | ﹤0.01% |
11,322
+209
| +2% | +$1.27K |
|
2867
Sight Sciences
SGHT
$456M
| $72K | ﹤0.01% |
11,271
| – | – |
|
2868
BARK
BARK
$96.3M
| $71K | ﹤0.01% |
2,177
+216
| +11% | +$7.03K |
|
2869
Clarus
CLAR
$141M
| $71K | ﹤0.01% |
15,751
| – | – |
|
|
NXDT
2870
NexPoint Diversified Real Estate Trust
NXDT
$250M
| $71K | ﹤0.01% |
+11,275
| New | +$66.9K |
|
2871
Solid Power
SLDP
$536M
| $71K | ﹤0.01% |
51,882
+6,347
| +14% | +$10K |
|
2872
Westrock Coffee
WEST
$807M
| $71K | ﹤0.01% |
10,830
| – | – |
|
2873
Codexis
CDXS
$175M
| $70K | ﹤0.01% |
22,720
+1,926
| +9% | +$5.96K |
|
2874
Wheels Up
UP
$190M
| $70K | ﹤0.01% |
1,443
| – | – |
|
|
KLRS
2875
Kalaris Therapeutics
KLRS
$93.8M
| $70K | ﹤0.01% |
3,735
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.